Archive

Shanghai, China (June 9, 2020) – Shanghai ChemPartner announced the additional investments the company is making into its biologics business unit to further its capabilities and capacity in biologics discovery through development and manufacturing. “ChemPartner has rich experience in providing biologics discovery and development services,” said Wei Tang, CEO at ChemPartner. “Our exceptional scientists on […]

Shanghai, China (May 12, 2020) – Shanghai ChemPartner announced they have entered into a non-exclusive agreement with the Mount Sinai Health System (Mount Sinai) to assist in a trial production run of a component of the Mount Sinai COVID-19 serological assay that recently received Emergency Use Authorization from the U.S. Food and Drug Administration for […]

SAN FRANCISCO, Calif. and SHANGHAI, China. (April 15, 2020) – In a new collaboration, Chempartner Corporation (ChemPartner), the US arm of a leading pre-clinical contract research and development organization (CRO), is partnering with scientists at Gladstone Institutes, an independent biomedical research organization, to accelerate the discovery of novel therapeutics and diagnostics for the novel coronavirus, […]

Shanghai, China (March 17, 2020) – Shanghai ChemPartner announced the opening of a new, state-of-the-art, 24,000 m2 laboratory facility in the Zhangjiang Hi-Tech Park in Shanghai, China. The building, operating as ChemPartner’s new Global Operation Center, houses approximately 700 employees and new laboratories for ChemPartner’s discovery chemistry, biology and pharmacology, and the DMPK and exploratory […]

Shanghai, China (December 17, 2019) – Shanghai ChemPartner announced the appointment of Jie Jack Li, Ph.D. as a Vice President of Discovery Chemistry at the Company headquarters in Shanghai, China. Dr. Li is an established chemist with over 20 years of experience in both medicinal chemistry and process chemistry. He is also widely published as […]

Contract manufacturers play a significant role when it comes to manufacturing medical products. By partnering with the right CM, a medical device manufacturer can save plenty of time and overhead costs. Life sciences companies need CMOs due to the potential rise in the number of products that are going through preclinical and clinical development and […]

Shanghai, China(Mar 28, 2019) – Shanghai ChemPartner today announced the appointment of Teddy Yang, Ph.D. as the Vice President and Head of Biologics Discovery at the company headquarters in Shanghai, China. Dr. Yang has more than 20 years of experience in the pharmaceutical industry. He has previously worked in Genentech, Novartis Institute for Biomedical Research, […]

Shanghai, China (March X, 2019) – March 25-27, 2019, ChemPartner will attend the 13th Annual International Partnering Conference BIO-Europe Spring in Vienna, Austria. With nearly 1,500 companies from 55 countries around the world, BIO-Europe is set to be a premier venue to engage with global life science partners. To schedule a meeting with ChemPartner, you may […]

ChemPartner, a leader in Peptide Synthesis and Development, will be at the Boulder Peptide Symposium, Sept. 24-27, 2018 in Boulder, Colorado. The program was organized by Dr. Yvonne Angell, who is the Head of Peptide Operations at ChemPartner. There are 43 speakers, including a Showcase of emerging Peptide Companies, a CEO roundtable, a Peptide Analytics […]

SHANGHAI, Aug. 16, 2018 /PRNewswire/ — Shanghai  ChemPartner, a leading life science organization providing high-quality and cost-effective drug discovery and development  services, announced the closure of the merger deal with Quantum Hi-Tech China Biological. Quantum, in a press release in 2017, announced their intent to join with Shanghai ChemPartner, a science-drive, technology-based Contract Research and Contract Manufacturing Organization (CRO/CMO) serving […]